Showing results (521-530 of 831) with videos related to

Sort By:
Pageof 84
Cancer|August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemiaDeborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.
Leukemia & Lymphoma|October 14, 2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomesOhad Benjamini, Preetesh Jain, Long Trinh, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2014
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignanciesEleonora Marostica, Juthamas Sukbuntherng, David Loury, et al.
Cancer|May 2, 2015
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomesSameer A Parikh, Jose F Leis, Kari G Chaffee, et al.
Leukemia & Lymphoma|November 26, 2016
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Sameer A Parikh, Peter A Noseworthy, et al.
British Journal of Haematology|November 19, 2016
Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centresAnthony Mato, Chadi Nabhan, Neil E Kay, et al.
American Journal of Hematology|July 29, 2016
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patientsStefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
Blood|September 11, 2007
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphomaJames R Cerhan, Stephen M Ansell, Zachary S Fredericksen, et al.
British Journal of Haematology|July 16, 2022
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemiaPaul J Hampel, Kari G Rabe, Timothy G Call, et al.
Pageof 84